Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Takemasa Ohki"'
Autor:
Kazuki Yoshida, Takemasa Ohki, Nobuyuki Aotsuka, Takanobu Utsumi, Mayuko Ishige, Hirohisa Kishi, Hiroshi Nakamachi, Shigeru Hosoki
Publikováno v:
The Japanese Journal of Urology. 103:631-635
A 60-year-old man with a history of acute myelogenous leukemia (AML) presented with a complaint of right groin mass. Three years ago the patient underwent an allogeneic bone marrow transplantation. Owing to successful engraftment, remission was achie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b65c483a0d19f43d0b66858f86facff4
https://doi.org/10.5980/jpnjurol.103.631
https://doi.org/10.5980/jpnjurol.103.631
Autor:
Naohide Sato, Takemasa Ohki, Hiroyoshi Suzuki, Tetsuro Onishi, Kazuo Mikami, Ken-ichi Egoshi, Akira Komiya, Hiroomi Nakatsu, Sho Ota, Yukio Naya, Tomohiko Ichikawa, Yusuke Awa, Kazuhiro Araki
Publikováno v:
International Journal of Urology. 17:555-562
Objectives: To investigate the benefit of α1-adrenoceptor antagonist naftopidil on the quality of life (QOL) of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH/LUTS). Methods: A total of 99 men with BPH/LUT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32548d47a261b3bf16813f3155e62dc7
https://doi.org/10.1111/j.1442-2042.2010.02518.x
https://doi.org/10.1111/j.1442-2042.2010.02518.x
Autor:
Yusuke Awa, Takemasa Ohki, Hiroyoshi Suzuki, Tomohiko Ichikawa, Yuri Sakurayama, Ken-ichi Egoshi, Tatsuya Okano, Sho Ota, Satoshi Hamano, Ikuo Mori
Publikováno v:
International Journal of Urology. 15:709-715
Objectives: To examine the effect of alpha 1D/A adrenoceptor inhibitor naftopidil on health-related quality of life (QOL) in men with benign prostatic hyperplasia (BPH). Methods: A total of 56 newly diagnosed patients with symptomatic BPH were prospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea656e0be097f0db5493bc1d64519b7a
https://doi.org/10.1111/j.1442-2042.2008.02097.x
https://doi.org/10.1111/j.1442-2042.2008.02097.x
Autor:
Yusuke Awa, Hiroomi Nakatsu, Tatsuya Okano, Yuzo Furuya, Hiroyoshi Suzuki, Masashi Yano, Ken-ichi Egoshi, Takemasa Ohki, Tomohiko Ichikawa, Kazuo Mikami, Satoru Hamano, Sho Ota
Publikováno v:
International Journal of Urology. 13:1202-1206
Aim: To examine the efficiency of α1-blocker treatment on disease-specific and generic quality of life (QOL) in men with clinically diagnosed benign prostatic hyperplasia (BPH), the improvement of QOL scores with International prostate symptom score
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9527ca0057f49bc579f81f1d4b72e8ad
https://doi.org/10.1111/j.1442-2042.2006.01594.x
https://doi.org/10.1111/j.1442-2042.2006.01594.x
Publikováno v:
Urology. 45:700-705
Objectives A case report is presented of 2 patients whose levels of serum prostate-specific antigen (PSA) improved after the withdrawal of a steroidal antiandrogen. Methods Two cases with prostate cancer had been treated with surgical castration and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3307242d0cf554413de5063aa1f9374c
https://doi.org/10.1016/s0090-4295(99)80070-3
https://doi.org/10.1016/s0090-4295(99)80070-3
Publikováno v:
International Journal of Urology. 1:263-267
To compare levels of gamma-seminoprotein (gamma-Sm) assayed by original and revised assay systems, blood was obtained every 4 h over a 32-h period from 8 untreated prostate cancer patients. Serum levels of prostate specific antigen (PSA) were also ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fba2fe948aaf6a187eef2fd9136ff5e
https://doi.org/10.1111/j.1442-2042.1994.tb00047.x
https://doi.org/10.1111/j.1442-2042.1994.tb00047.x
Autor:
Akira, Komiya, Hiroyoshi, Suzuki, Yusuke, Awa, Ken-ichi, Egoshi, Tetsuro, Onishi, Hiroomi, Nakatsu, Takemasa, Ohki, Kazuo, Mikami, Naohide, Sato, Kazuhiro, Araki, Sho, Ota, Yukio, Naya, Tomohiko, Ichikawa
Publikováno v:
International journal of urology : official journal of the Japanese Urological Association. 17(6)
To investigate the benefit of alpha1-adrenoceptor antagonist naftopidil on the quality of life (QOL) of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH/LUTS).A total of 99 men with BPH/LUTS were prospectivel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d0a06fe58043f3658fb3b83b126d5dfc
https://pubmed.ncbi.nlm.nih.gov/20370847
https://pubmed.ncbi.nlm.nih.gov/20370847
Autor:
Hiroyoshi, Suzuki, Masashi, Yano, Yusuke, Awa, Hiroomi, Nakatsu, Ken-Ichi, Egoshi, Kazuo, Mikami, Sho, Ota, Tatsuya, Okano, Satoru, Hamano, Takemasa, Ohki, Yuzo, Furuya, Tomohiko, Ichikawa
Publikováno v:
International journal of urology : official journal of the Japanese Urological Association. 13(9)
To examine the efficiency of alpha1-blocker treatment on disease-specific and generic quality of life (QOL) in men with clinically diagnosed benign prostatic hyperplasia (BPH), the improvement of QOL scores with International prostate symptom score (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f0703b86e1b57503f7eb64d187928d6c
https://pubmed.ncbi.nlm.nih.gov/16984553
https://pubmed.ncbi.nlm.nih.gov/16984553
Publikováno v:
Japanese journal of clinical oncology. 26(2)
To determine the changes in histologic features during the course of prostate cancer under longterm endocrine therapy, histologic grade and argyrophilic nucleolar organizer regions (AgNORs) were examined in specimens before treatment, at relapse, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::197edbdea2f695d4b787ce31f26b901d
https://pubmed.ncbi.nlm.nih.gov/8609699
https://pubmed.ncbi.nlm.nih.gov/8609699
Autor:
Koichiro Akakura, Susumu Akimoto, Manabu Kuriyama, Jun Shimazaki, Yukimichi Kawada, Takemasa Ohki
Publikováno v:
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology. 86(2)
Prostate specific antigen (PSA) levels after total prostatectomy or radiation therapy to localized prostate cancer and also during endocrine therapy are within normal range. Therefore, it is necessary to use hyper sensitive PSA assay kits for early d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c18732ccf4efff140a1b71fb54bf9b1
https://pubmed.ncbi.nlm.nih.gov/7534843
https://pubmed.ncbi.nlm.nih.gov/7534843